Company
Neurotrope, Inc. (0001513856)
Standardized SEC financial data for Neurotrope, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001513856 · Pharmaceutical Preparations.
Return on equity
-86.9%
Free cash flow
-$11.9M
Current ratio
37.31×
Income statement
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| R&D expense | $5.6M | $4.5M | $4.6M | $4.5M |
| SG&A expense | $3.4M | $5.5M | $4.0M | $6.7M |
| Pretax income |
Standardized from Neurotrope, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Cash & equivalents | $25.8M | $16.1M | $28.9M | $17.4M |
| Total current assets | $25.9M | $16.4M | $29.5M | $17.9M |
Cash flow
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Operating cash flow | -$7.4M | -$11.0M | -$7.7M | -$11.9M |
| Capital expenditures | $3K | $4K | $3K | $5K |
Get 0001513856 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001513856/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001513856/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"